Federal Aviation Administration

Guide for Aviation Medical Examiners

Pharmaceuticals (Therapeutic Medications)
Acne Medications

  1. Code of Federal Regulations:
    • First-Class Airman Medical Certificate: 67.113(c)
    • Second-Class Airman Medical Certificate: 67.213(c)
    • Third-Class Airman Medical Certificate: 67.313(c)

  2. Medical History:
    For applicants using isotretinoin (Accutane), there is a mandatory 2-week waiting period after starting isotretinoin prior to consideration. This medication can be associated with vision and psychiatric side effects of aeromedical concern - specifically decreased night vision/ night blindness and depression. These side-effects can occur even after cessation of isotretinoin. A report must be provided with detailed, specific comment on presence or absence of psychiatric and vision side-effects. The AME must document these findings in Block 60, Comments on History and Findings. Some applicants will have to be deferred. For applicants issued, there must be a NOT VALID FOR NIGHT FLYING restriction on the medical certificate. A waiting period and detailed information is required to remove this restriction. The restriction cannot be removed until all the requirements are met. See Pharmaceutical Considerations below.

  3. Aeromedical Decision Considerations:
    See Item 40, Skin.

  4. Protocol: N/A

  5. Pharmaceutical Considerations:
    • Use of isotretinoin must be permanently discontinued for at least 2 weeks prior to consideration date (confirmed by the prescribing physician) and;
    • Eye evaluation must be done in accordance with specifications in 8500-7 and;
    • The airman must provide a signed statement of discontinuation that:
      • Confirms the absence of any visual disturbances and psychiatric symptoms, and
      • Acknowledges requirement to notify the FAA and obtain clearance prior to performing any aviation safety-related duties if use of isotretinoin is resumed

Page Last Modified: 12/05/11 08:48 EST

This page can be viewed online at: http://www.faa.gov/about/office_org/headquarters_offices/avs/offices/aam/ame/guide/pharm/acne/